Targeted Lung Cancer Delivery Using Tiny Lipid‑Coated MOF Carriers

A new approach to lung cancer treatment uses a tiny metal‑organic framework (MOF) wrapped in lipids to carry the drug anlotinib directly to tumor cells. The MOF, called MIL‑101(Fe), is engineered to be very small so it can circulate in the bloodstream without getting trapped in healthy tissues.